Lapatinib Tablets

Product/Composition Lapatinib Tablets
Form Tablet
Strength 250mg
Therapeutic use Anti Cancer
Package Insert/Leaflet Available upon request

Lapatinib Tablets are a prescription medicine that belongs to the class of tyrosine kinase inhibitors and are primarily used in certain types of cancer treatment.

Here are the key details:

  • Main Use: Prescribed for the treatment of HER2-positive breast cancer, often in patients whose cancer has progressed after other therapies. It may be used alone or in combination with other anticancer medicines.

  • How It Works: Lapatinib blocks the activity of certain proteins (tyrosine kinases) involved in the growth and spread of cancer cells, slowing tumor progression.

  • Administration: Taken orally, usually once daily on an empty stomach or as instructed by the doctor. The dosage depends on the type of cancer and individual patient factors.

  • Common Side Effects: Diarrhea, nausea, vomiting, rash, fatigue, headache, and mild liver enzyme changes.

  • Serious Concerns: May rarely cause heart problems, severe liver toxicity, severe diarrhea leading to dehydration, or lung complications. Regular monitoring by a doctor is required.

  • Precautions:

    • Not recommended in patients with pre-existing heart conditions unless monitored carefully.

    • Liver function tests are usually checked regularly during treatment.

    • Avoid taking other medications or supplements that may interact without doctor guidance.

  • Storage: Store at room temperature, away from moisture, heat, and direct sunlight.